1. Home
  2. DNTH vs EYE Comparison

DNTH vs EYE Comparison

Compare DNTH & EYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$95.00

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo National Vision Holdings Inc.

EYE

National Vision Holdings Inc.

HOLD

Current Price

$25.35

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNTH
EYE
Founded
2015
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
DNTH
EYE
Price
$95.00
$25.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
9
Target Price
$121.00
$31.22
AVG Volume (30 Days)
844.8K
1.3M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
202.78
EPS
N/A
0.37
Revenue
$2,036,000.00
$1,987,488,000.00
Revenue This Year
N/A
$5.56
Revenue Next Year
$29.48
$6.58
P/E Ratio
N/A
$67.32
Revenue Growth
N/A
9.00
52 Week Low
$16.77
$10.75
52 Week High
$92.27
$30.02

Technical Indicators

Market Signals
Indicator
DNTH
EYE
Relative Strength Index (RSI) 76.73 46.99
Support Level $33.94 $25.33
Resistance Level N/A $29.37
Average True Range (ATR) 4.54 1.49
MACD 0.13 0.01
Stochastic Oscillator 97.35 50.86

Price Performance

Historical Comparison
DNTH
EYE

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

About EYE National Vision Holdings Inc.

National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.

Share on Social Networks: